Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
30.83
+0.81 (2.70%)
Aug 5, 2026, 4:00 PM EDT - Market closed
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.9 billion as of August 6, 2026. Its market cap has increased by 42,295.14% in one year.
Market Cap
1.90B
Enterprise Value
1.36B
1-Year Change
42,295.14%
Ranking
Category
Stock Price
$30.83
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.90B, an increase of 414.59%. That is a compound annual growth rate of 32.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 1.90B | 5,059.81% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GH Research | 1.97B |
| Iovance Biotherapeutics | 1.96B |
| Aurinia Pharmaceuticals | 1.95B |
| Mesoblast | 1.95B |
| Generate Biomedicines | 1.92B |
| Agios Pharmaceuticals | 1.87B |
| Forte Biosciences | 1.87B |
| Ocular Therapeutix | 1.87B |